Clinically reviewed by Dr. Hemal V. Mehta, MD and Kate Sherman, PA-C, Vita Nova Stem Cell Professionals
If a surgeon has told you that your shoulder needs an operation and you are not ready to say yes, you are asking the right question. Surgery is one path. It is not always the only one, and for many shoulder conditions it is not the first one that should be tried.
Shoulder pain therapy without surgery covers more ground than most patients realize. Cortisone, physical therapy, PRP, and regenerative approaches each work through different mechanisms, address different problems, and carry different timelines. Understanding what each option actually does, where it works, and where it falls short is what lets you make a decision you will not second-guess later.
Why Standard Care Often Stalls
Most shoulder patients follow the same sequence: rest, anti-inflammatories, cortisone, physical therapy, then a referral to a surgeon. Each step is clinically reasonable. But for a significant number of patients, none of them fully resolves the underlying problem.
The reason depends on the condition. Tendon degeneration is not an inflammatory process that cortisone can reverse. Cartilage loss in shoulder osteoarthritis is structural, not something PT rebuilds. Chronic bursitis often returns because the mechanical cause was never addressed.
Standard care manages symptoms. When tissue damage is what is driving the pain, symptom management buys time but does not close the gap. That is where the map of non-surgical options becomes more important.
Corticosteroid Injections
Cortisone reduces inflammation quickly. For acute flares, bursitis, and impingement it works well and provides real relief. Most orthopedic providers recommend limiting injections to three to four per joint per year, because repeated cortisone over time may weaken tendon tissue and accelerate cartilage damage.
Cortisone is a time-buying tool. Useful when the goal is to reduce acute pain while pursuing other approaches. Less useful as a primary strategy when the underlying problem is structural degeneration rather than inflammation alone.
Physical Therapy
Physical therapy focuses on strengthening rotator cuff musculature, improving scapular mechanics, and restoring range of motion. Impingement syndrome, early bursitis, and partial tears with intact tissue often respond well to a structured program.
Where it falls short: when the underlying tissue is too degenerated to respond to mechanical loading. A patient with significant tendon degeneration or moderate-to-advanced osteoarthritis may plateau in PT because the tissue cannot remodel adequately through exercise alone.
Physical therapy is rarely wasted even when it does not resolve the primary pain. It builds the surrounding muscle support that makes every other intervention more effective.
Hyaluronic Acid Injections
Hyaluronic acid injections add lubrication to the joint. FDA-approved for knee osteoarthritis and used off-label in the shoulder. For patients whose primary complaint is joint stiffness and grinding rather than acute inflammation, they may provide months of symptom relief.
The mechanism is not regenerative. Hyaluronic acid does not repair cartilage. It reduces friction and may carry some anti-inflammatory effect. A reasonable middle step for patients who have not responded to cortisone but are not yet pursuing more advanced approaches.
Platelet-Rich Plasma (PRP) Therapy
PRP uses your own blood, processed to concentrate platelets, then injected into the affected shoulder tissue under image guidance. Platelets carry growth factors that signal tissue repair and reduce inflammation. Because PRP is derived from your own blood, there is no rejection risk.
Research on PRP for shoulder conditions shows meaningful patient-reported improvements in rotator cuff tendinopathy, partial tears, and frozen shoulder. A 2024 meta-analysis of 14 randomized controlled trials found PRP injections for frozen shoulder significantly improved pain and range of motion compared to cortisone, with longer-lasting effects and no major adverse reactions.
PRP is not a guaranteed outcome. Most effective for tendon pathology and mild-to-moderate osteoarthritis. Less likely to produce results in severe tissue degeneration or complete tears.
Regenerative Cell-Based Therapy
Cell-based approaches take biological repair further than PRP. Where PRP delivers growth factors to stimulate healing, regenerative cell therapy introduces cells that may contribute to new tissue formation. For shoulder conditions where the tissue itself is the problem, not just the inflammatory response around it, this distinction matters clinically.
Conditions most often considered for regenerative cell approaches include partial rotator cuff tears that have not responded to PT or PRP, early-to-moderate shoulder osteoarthritis, labral pathology where surgery is being weighed, and chronic tendinopathy unresponsive to other interventions.
Cell-based therapies for orthopedic shoulder conditions are not FDA-approved. Any responsible provider will state this clearly before any procedure. This does not mean they are unproven. It means the regulatory pathway is ongoing and clinical use requires informed consent and realistic expectations.
Provider quality varies significantly in this space. Cell source, processing method, documented cell count, image guidance precision, and physician experience each affect outcomes in ways that make provider evaluation a clinically meaningful decision.
How to Think About Sequencing
These options are not mutually exclusive. The more useful question is not which one, but what have you actually tried, in what order, and what did each step tell you about your shoulder.
A reasonable sequence for most non-acute shoulder conditions: physical therapy first to establish baseline and rule out mechanical causes. Cortisone if acute inflammation is limiting PT participation. PRP if tendon pathology persists after PT. Cell-based approaches if PRP has been tried without adequate response, or if the extent of tissue damage makes a more regenerative approach the appropriate next step.
Surgery is appropriate in certain cases. Complete rotator cuff tears often require it. Severe instability, advanced bone-on-bone arthritis, and acute fractures are situations where non-surgical approaches have clear limits. Knowing when surgery is the right call is as important as knowing when it is not.
What Makes Someone a Candidate
Candidacy for shoulder pain therapy without surgery depends on the specific condition and its severity on imaging, how long symptoms have been present, what has already been tried, overall health, and realistic expectations about what non-surgical care can achieve.
The one consistent recommendation across every option listed here: see a physician who will give you an honest assessment rather than a pre-determined answer. A provider who tells every patient they are a candidate for one specific intervention, or that surgery is the only option, is not giving you individualized care. A good evaluation starts with your imaging and history, acknowledges what you have tried, and is honest about where the evidence is strong and where it is limited.
For Nashville-Area Patients
If you are in the Nashville or Franklin, Tennessee area and have already worked through standard care without full resolution, and want to understand whether a regenerative care plan makes sense for your specific shoulder condition, Vita Nova Stem Cell Professionals in Franklin offers physician-led evaluations with no obligation to proceed.
Vita Nova Stem Cell Professionals
Phone: (615) 801-8005
Address: 4601 Carothers Pkwy, Franklin, TN
Website: vitanovatn.com
DisclaimerThis article is for informational purposes only and does not constitute medical advice. PRP and cell-based therapies for orthopedic shoulder conditions are not FDA-approved for most indications. Individual results vary. Consult a qualified physician before making decisions about care.
Sources
- Zhang WB, Ma YL, Lu FL, et al. The clinical efficacy and safety of platelet-rich plasma on frozen shoulder: a systematic review and meta-analysis of randomized controlled trials. BMC Musculoskeletal Disorders. 2024;25:718.
- McAlindon TE, LaValley MP, Harvey WF, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA. 2017;317(19):1967-1975.
- Berner JE, Nicolaides M, Ali S, et al. Pharmacological interventions for early-stage frozen shoulder: a systematic review and network meta-analysis. Rheumatology. 2024;63(12):3221-3233.
- U.S. Food and Drug Administration. FDA regulation of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 21 CFR Part 1271.